Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT02509754

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02509754
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02509754. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function
Acronym
AFARC-LVF
Condition
Persistent Atrial Fibrillation
Condition
Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction
Intervention (Procedure)
Atrial fibrillation catheter ablation
Intervention (Procedure)
Rate control
Lead sponsor
University of Turin, Italy (class: other)
Collaborator
Centro Cardiologico Monzino (class: other)
Collaborator
Humanitas Research Hospital IRCCS, Rozzano-Milan (class: other)
Collaborator
University of Padova (class: other)
Collaborator
Policlinico Casilino ASL RMB (class: other)

Record details

Record id
cardio:ct-nct02509754
Content hash
3e62ce8db77e6c6f5374be8b179178de00f7669532528ea1efab37c4532600b6